Page last updated: 2024-11-02

1,2-cyclohexanediamine and Hypertension, Pulmonary

1,2-cyclohexanediamine has been researched along with Hypertension, Pulmonary in 1 studies

1,2-cyclohexanediamine: RN given refers to cpd without isomeric designation

Hypertension, Pulmonary: Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
GrĂ¼nig, E1
Benjamin, N1
Behr, J1
Skowasch, D1
Milger-Kneidinger, K1
Halank, M1
Kuebler, WM1
Kovacs, G1
Lichtblau, M1
Guth, S1
Apitz, C1
Kaemmerer, H1
Tello, K1
Ulrich, S1

Other Studies

1 other study available for 1,2-cyclohexanediamine and Hypertension, Pulmonary

ArticleYear
[The new European Guidelines for Pulmonary Hypertension with Updated Commentary of the PH-DACH Conference - A position paper of the German Society for Pneumology and Respiratory Medicine (DGP)].
    Pneumologie (Stuttgart, Germany), 2023, Volume: 77, Issue:11

    Topics: Germany; Humans; Hypertension, Pulmonary; Pulmonary Medicine

2023